Company profile
NeuroSense Therapeutics
Creatively and diligently moving fast towards an effective treatment for people with ALS.
- Industry
- Biotechnology Research
- Employees
- 28
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2017
- LinkedIn followers
- 13,563
- Office locations
- 2
NeuroSense Therapeutics company summary
NeuroSense Therapeutics is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2017. On LinkedIn the company has around 28 employees and 13,563 followers. The company lists 2 office locations. Its listed specialties include Drug Development, ALS, MND, Lou Gehrig's Disease, CNS.
What technology does NeuroSense Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NeuroSense Therapeutics
Advancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally. $NRSN
Specialties
Where is NeuroSense Therapeutics located?
NeuroSense Therapeutics lists 2 office locations.
Compare companies similar to NeuroSense Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NeuroSense Therapeutics neurosense-tx.com | Biotechnology Research | 28 | 2017 | Cambridge, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NeuroSense Therapeutics
What does NeuroSense Therapeutics do?
Advancing research, development and therapy for ALS and additional CNS indications. NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally. $NRSN
How many employees does NeuroSense Therapeutics have?
NeuroSense Therapeutics has around 28 employees on LinkedIn.
Where is NeuroSense Therapeutics headquartered?
NeuroSense Therapeutics is headquartered in Cambridge, Massachusetts.
Where does NeuroSense Therapeutics have offices?
NeuroSense Therapeutics lists 2 office locations, including Cambridge, Massachusetts, US; Herzliya, Israel, IL.
When was NeuroSense Therapeutics founded?
NeuroSense Therapeutics was founded in 2017.
Build a lead list from companies like NeuroSense Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.